Florian Hamon

Head of New Drug Application Group (Cmc) @Curium Pharma

Paris, FR
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Sep 2018 — Present

Head of New Drug Application Group (Cmc) @Curium Pharma

View department →

EDUCATION

N/A

Ecole Nationale Supérieure de Chimie de Montpellier

Diplôme d'ingénieur

2015 — 2015

For Drug Consulting

CRA - Clinical Research Associate

2003 — 2004

KTH Royal Institute of Technology

Civilingenjör

2005 — 2008

Université de Poitiers

PhD

SKILLS

Life SciencesScienceOrganic SynthesisOrganic ChemistryAnalytical ChemistryMedicinal ChemistryTeam ManagementR&DBiotechnologyResearchHplcChemistryScifinderAssay DevelopmentDnaProject ManagementCharacterizationNmrSpectroscopy

ABOUT FLORIAN HAMON

Currently Head of New Drug Application group (14 people) at Curium Pharma in charge of- Development (manufacturing process and analytical methods) of several molecules in SPECT and PET (F18, Cu64 compounds) in accordance with GMP and European pharmacopoeia- Development of small volume injectable product- Radiochemistry - Leading deployment of new molecules over 30 Europeans sites, project management in multicultural environment Multidisciplinary background- French-german baccalaureate and French-Swedish chemistry engineers degrees (National school of Chemistry of Montpellier and 18 months in KTH and Karolinska Institute in Stockholm)- PhD (3 years) in therapeutic chemistry and Teaching assistant (1 year) in Poitiers university - Senior project manager (5 years) at Curie Institute in preclinical studies on new targets in oncology

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Florian Hamon — Head of New Drug Application Group (Cmc) at Curium Pharma in Paris, FR | Unifers